We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Gastroenterology

Advancing Donation After Circulatory Death Liver Transplantation: National Evidence Supporting Normothermic Regional and Machine Perfusion as Standards of Care

MedXY Editorial Team•Jun 25, 2026•Gastroenterology
DCD liver transplantationgraft survivalnormothermic machine perfusionnormothermic regional perfusion

Highlight

This national comparative analysis of 4,632 donation after circulatory death (DCD) liver transplants in the United States demonstrates that both normothermic regional perfusion (NRP) and normothermic machine perfusion (NMP) significantly improve graft survival compared to conventional super rapid recovery with static cold storage (SRR-SCS). Importantly, no significant survival differences were observed between NRP and NMP, affirming their complementary utility. This evidence supports the adoption of both techniques as new standards of care in DCD liver transplantation.

Study Background

Liver transplantation using grafts from donation after circulatory death donors has historically been limited by inferior outcomes relative to donation after brain death donors. A major challenge has been the increased incidence of ischemic-type biliary injury, leading to graft dysfunction and failure. Improved procurement and preservation strategies to mitigate ischemia-reperfusion injury have become critical to enhancing DCD liver graft viability and outcomes. Normothermic regional perfusion (NRP) and normothermic machine perfusion (NMP) have emerged as promising approaches, maintaining organs at physiologic temperature with oxygenated blood or perfusate to improve viability and reduce ischemic injury.

Study Design

This retrospective cohort study analyzed national data from the United Network for Organ Sharing (UNOS) registry covering 2022 to 2024. The study population included 4,632 DCD liver transplant cases stratified by procurement and preservation methods: super rapid recovery (SRR) vs. normothermic regional perfusion (NRP) for procurement, and static cold storage (SCS) vs. normothermic machine perfusion (NMP) for preservation. NMP cases were further divided into on-site initiation and back-to-base initiation. On-site NMP was directly recorded in UNOS, while NRP and back-to-base NMP were identified using surrogate markers. Propensity score matching was applied to balance covariates and compare graft survival (GS) and overall survival (OS) across cohorts.

Key Findings

Among identified cases, the most common approach was SRR-NMP (56.9%), followed by SRR-SCS (20.2%), NRP-SCS (12.1%), and NRP-NMP (10.8%).

Comparative analyses revealed that:

  • SRR-NMP was associated with significantly improved graft survival compared to SRR-SCS (hazard ratio [HR] 0.54; 95% confidence interval [CI] 0.32–0.92), highlighting the benefit of normothermic machine preservation over traditional cold storage following SRR procurement.
  • NRP followed by SCS also showed a significant reduction in graft loss risk versus SRR-SCS (HR 0.42; 95% CI 0.29–0.61), underscoring the efficacy of normothermic regional reperfusion during procurement in improving graft outcomes.
  • Between NRP-SCS and SRR-NMP, there were no statistically significant differences in graft survival, suggesting comparable effectiveness of these two modern approaches.
  • Adding NMP to livers procured with NRP (NRP-NMP) did not further improve outcomes compared to NRP followed by SCS alone, indicating that NMP may not provide additional benefit after NRP.

Overall survival outcomes mirrored graft survival trends. These findings establish that both NRP and NMP are superior to the historical SRR-SCS approach and serve complementary roles rather than being mutually exclusive alternatives.

Expert Commentary

This pioneering national analysis in the U.S. substantiates the clinical value of normothermic perfusion strategies in overcoming the ischemic challenges inherent in DCD liver transplantation. By maintaining the organ in a physiologic state at procurement (NRP) or during preservation (NMP), these techniques mitigate ischemia-reperfusion injury, particularly to the biliary epithelium, which has resulted in historically higher rates of biliary complications and graft loss.

The comparable graft survival between NRP and NMP suggests that centers may tailor their use based on logistics and resources: NRP requires specialized surgical expertise and facilities for in situ reperfusion, while NMP offers the flexibility of ex vivo organ assessment and preservation.

However, the lack of incremental benefit from combining NRP with NMP indicates a potential ceiling effect in ameliorating ischemic injury, and that resource allocation might prioritize deploying either technique effectively rather than both in sequence.

Limitations include reliance on surrogate markers in UNOS data, potential unmeasured confounders, and variations in machine perfusion protocols across centers. Nonetheless, the large sample size and rigorous propensity matching strengthen the validity of these findings.

Conclusion

This comprehensive national comparative study confirms that both normothermic regional perfusion during procurement and normothermic machine perfusion during preservation significantly improve graft survival after DCD liver transplantation compared to the historic standard of super rapid recovery with static cold storage. Their complementary roles enable transplantation centers to adopt strategies tailored to their infrastructure to mitigate ischemic biliary injury effectively.

These results support the adoption of NRP and NMP as new standards of care in U.S. DCD liver transplantation, with significant potential to expand the donor pool and improve transplant outcomes. Future prospective trials and cost-effectiveness analyses will further guide optimized protocol selection and implementation.

Funding and ClinicalTrials.gov

The study was supported by institutional funding; no specific clinical trial registration is reported. Authors disclose no conflicts of interest.

References

1. Acuna SA, Dayala H, Jones-Carr ME, et al. Normothermic Machine and Regional Perfusion in U.S. DCD Liver Transplantation: A National Comparative Analysis Supporting Adoption as Standard of Care. Ann Surg. 2026 Jun 23. PMID: 42335023.
2. Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557(7703):50-56.
3. Watson CJE, Jochmans I. Normothermic Regional Perfusion: Resuscitating Graft Function and Expanding Use of Extended Criteria Donor Organs. Am J Transplant. 2020;20(12):3256-3261.
4. Czigany Z, Schlegel A, Verbeke L, et al. Continuous Normothermic Regional Perfusion Versus Abdominal Normothermic Machine Perfusion in Donation After Circulatory Death Liver Transplantation: Current Evidence and Perspectives. Transplantation. 2022;106(8):1539-1549.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Comparative Real-World Outcomes of Hypothermic Oxygenated and Normothermic Machine Perfusion in Liver TransplantationThis international cohort study evaluates hypothermic oxygenated perfusion (HOPE) versus normothermic machine perfusion (NMP) in liver transplantation, revealing comparable high graft survival despite differing donor risk profiles and highlSep 12, 2026Reevaluating Calcineurin Inhibitor Use in Identical Twin Kidney Transplants: Are We Overmedicating?Despite identical immunogenetic makeup, half of kidney transplant recipients from identical twins remain on calcineurin inhibitors, with no demonstrable benefit in rejection reduction or graft survival over 25 years, calling for critical reSep 4, 2026Enhancing Kidney Transplant Outcomes: The Combined Role of Normothermic Regional Perfusion and Hypothermic Machine Perfusion in Donation After Circulatory Death DonorsSequential use of normothermic regional perfusion and hypothermic machine perfusion in kidney transplants from DCD donors reduces delayed graft function, highlighting enhanced organ preservation strategies.Aug 17, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Normothermic Regional Perfusion: A Paradigm Shift in Pancreas and Islet Transplantation from DCD Donors
Normothermic regional perfusion (NRP) offers a promising approach to reduce ischemic injury in pancreas and islet transplantation using donation after circulatory death (DCD) donors, improving graft quality and expanding donor availability.
Aug 12, 2026
Determinants of One-Year Success in Descemet Membrane Endothelial Keratoplasty: Insights from the Diabetes Endothelial Keratoplasty StudyThis article examines factors influencing the one-year success rate of DMEK in treating corneal endothelial dysfunction, highlighting the impact of operative complications and donor-recipient variables based on findings from the Diabetes EnAug 2, 2026
Impact of Normothermic Regional Perfusion on Outcomes in Kidney Transplantation From Donors After Circulatory DeathIn a nationwide U.S. analysis of 21,010 adult DCD kidney transplants, normothermic regional perfusion lowered delayed graft function, shortened hospital stay, and improved graft and patient survival, with the greatest benefit in higher-riskJun 4, 2026